ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain
November 26, 2018A non-opioid drug developed by Pfizer and Eli Lilly met the main goals of a late-stage study, in which over half of the patients reported a significant reduction in osteoarthritis pain of the knee or hip. -
Pfizer & Lilly's non-opioid drug reduces pain in osteoarthritis
October 25, 2018Pfizer and Eli Lilly have announced data revealing that their nerve growth factor (NGF) inhibitor tanezumab met all three of its co-primary endpoints in the treatment of osteoarthritis (OA). -
Pfizer, Eli Lilly report detailed results from late-stage study of NGF inhibitor tanezumab in osteoarthritis pain
October 25, 2018Pfizer, Eli Lilly report detailed results from late-stage study of NGF inhibitor tanezumab in osteoarthritis pain
Pharma Sources Insight January 2025
